Citizens Jmp upgraded shares of Sana Biotechnology (NASDAQ:SANA – Free Report) from a market perform rating to an outperform rating in a report issued on Tuesday, Marketbeat reports. They currently ...

Fintel reports that on March 18, 2025, Citizens Capital Markets upgraded their outlook for Sana Biotechnology (NasdaqGS:SANA) ...

Sana Biotechnology ( NASDAQ: SANA) was upgraded to Market Outperform from Market Perform at Citizens as the research broker ...

Announced positive preliminary 12-week clinical results, building on already released 4-week results, of ongoing type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplan ...

Announced positive preliminary 12-week clinical results, building on already released 4-week results, of ongoing type 1 diabetes study showing ...

SEATTLE - Sana Biotechnology , Inc. (NASDAQ: SANA) reported a narrower-than-expected loss for the fourth quarter of 2024, sending shares up 2.2% in after-hours trading. The biotechnology company ...

Reports cash equivalents, and marketable securities as of December 31, were $152.5M compared to $205.2M as of December 31, 2023. The decrease ...

SEATTLE (AP) — SEATTLE (AP) — Sana Biotechnology Inc. (SANA) on Monday reported a loss of $49.1 million in its fourth quarter. The Seattle-based company said it had a loss of 21 cents per share.

Fintel reports that on March 14, 2025, Jefferies initiated coverage of Sana Biotechnology (NasdaqGS:SANA) with a Buy ...